A Long-Term Safety Study of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT04702568 · TERMINATED
Trial details
- NCT number
- NCT04702568
- Sponsor
- BioCryst Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2023-10-04
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.